Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT03488667
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-19
First Post:
2018-03-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma
Sponsor:
University of Kansas Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-28
First Submit QC Date:
None
Study First Post Date:
2018-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-18
Last Update Post Date:
2023-05-19
Last Update Post Date Type:
ACTUAL